Press Releases

Cryoport, Inc.,a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences industry focused on the pharmaceutical and cell and gene therapy markets, today announced a new strategic partnership with Syneos Health® (NASDAQ: SYNH), the only fully...

Charles River Laboratories International, Inc. and Rznomics Inc., a South Korea-based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, announced a viral vector contract development and manufacturing organization (CDMO) partnership. Rznomics will leverage Charles River’s viral vector...

Airnov Healthcare Packaging, a global leader in controlled atmosphere packaging, has launched a brand-new advanced solution which promises to provide substantial benefits to the pharmaceutical industry. IDC® (Integrated Desiccant Closure), enables manufacturers to reduce the number of components that would...

Abzena, the leading end-to-end integrated CDMO for Antibody Drug Conjugates (ADCs) and complex biologic molecules, announced that Matthew Stober has joined as their new Chief Executive Officer. Matthew Stober was most recently CEO of therapeutic companies CastleVax and Istari Oncology. ...

Novotech, the leading Asia Pacific-centered biotech CRO announced the acquisition of CBR International, a global product development, clinical oversight and strategic regulatory operations group. CBR was founded in 2002 as a consultancy company focused on assisting biotechnology and pharma companies...

Novotech announced the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the continent. The acquisition is part of Novotech's global expansion program. EastHORN was established in 2004 and has...

Samsung Biologics, a leading contract development and manufacturing organization (CDMO), was awarded the Sustainable Markets Initiative’s Terra Carta Seal. The Terra Carta Seal, launched at COP26 by His Majesty King Charles III when he was Prince of Wales, recognises global...